海南医学
海南醫學
해남의학
HAINAN MEDICAL JOURNAL
2015年
1期
34-36
,共3页
张华%刘海生%旷艳春%肖少文%周阳永%刘杰
張華%劉海生%曠豔春%肖少文%週暘永%劉傑
장화%류해생%광염춘%초소문%주양영%류걸
右美托咪定%瑞芬太尼%丙泊酚%麻醉
右美託咪定%瑞芬太尼%丙泊酚%痳醉
우미탁미정%서분태니%병박분%마취
Dexmedetomidine hydrochloride%Remifentanil%Propofol%Anesthesia
目的:观察盐酸右美托咪定联合瑞芬太尼在骨科手术中的麻醉效果。方法将ASA分级为Ⅰ级或Ⅱ级的320例明确要采用区域阻滞麻醉的骨科手术患者随机分为试验组和对照组,每组各160例。试验组静脉注射盐酸右美托咪定联合瑞芬太尼辅助镇静,对照组静脉注射丙泊酚联合瑞芬太尼辅助镇静。记录两组给药前(T0),给药后10 min (T1)、20 min (T2)、30 min (T3)和患者苏醒后(T4)各时点的呼吸频率(RR)、平均动脉压(MAP)、心率(HR)、脉搏氧饱和度(SpO2)和警觉/镇静观察评定(OAA/S)评分情况。结果在T0、T4时间点两组研究对象观察指标差异均无统计学意义(P>0.05);对照组患者在T1、T2和T3时间点的RR和SPO2明显低于试验组,差异有统计学意义(P<0.05)。在手术过程中对照组患者出现呼吸抑制、上呼吸道梗阻和恶心呕吐等不良反应的发生率明显高于试验组(P<0.05)。结论区域阻滞麻醉采用盐酸右美托咪定联合瑞芬太尼比使用射丙泊酚联合瑞芬太尼具有较好的辅助镇静作用,安全性高,呼吸抑制程度较轻。
目的:觀察鹽痠右美託咪定聯閤瑞芬太尼在骨科手術中的痳醉效果。方法將ASA分級為Ⅰ級或Ⅱ級的320例明確要採用區域阻滯痳醉的骨科手術患者隨機分為試驗組和對照組,每組各160例。試驗組靜脈註射鹽痠右美託咪定聯閤瑞芬太尼輔助鎮靜,對照組靜脈註射丙泊酚聯閤瑞芬太尼輔助鎮靜。記錄兩組給藥前(T0),給藥後10 min (T1)、20 min (T2)、30 min (T3)和患者囌醒後(T4)各時點的呼吸頻率(RR)、平均動脈壓(MAP)、心率(HR)、脈搏氧飽和度(SpO2)和警覺/鎮靜觀察評定(OAA/S)評分情況。結果在T0、T4時間點兩組研究對象觀察指標差異均無統計學意義(P>0.05);對照組患者在T1、T2和T3時間點的RR和SPO2明顯低于試驗組,差異有統計學意義(P<0.05)。在手術過程中對照組患者齣現呼吸抑製、上呼吸道梗阻和噁心嘔吐等不良反應的髮生率明顯高于試驗組(P<0.05)。結論區域阻滯痳醉採用鹽痠右美託咪定聯閤瑞芬太尼比使用射丙泊酚聯閤瑞芬太尼具有較好的輔助鎮靜作用,安全性高,呼吸抑製程度較輕。
목적:관찰염산우미탁미정연합서분태니재골과수술중적마취효과。방법장ASA분급위Ⅰ급혹Ⅱ급적320례명학요채용구역조체마취적골과수술환자수궤분위시험조화대조조,매조각160례。시험조정맥주사염산우미탁미정연합서분태니보조진정,대조조정맥주사병박분연합서분태니보조진정。기록량조급약전(T0),급약후10 min (T1)、20 min (T2)、30 min (T3)화환자소성후(T4)각시점적호흡빈솔(RR)、평균동맥압(MAP)、심솔(HR)、맥박양포화도(SpO2)화경각/진정관찰평정(OAA/S)평분정황。결과재T0、T4시간점량조연구대상관찰지표차이균무통계학의의(P>0.05);대조조환자재T1、T2화T3시간점적RR화SPO2명현저우시험조,차이유통계학의의(P<0.05)。재수술과정중대조조환자출현호흡억제、상호흡도경조화악심구토등불량반응적발생솔명현고우시험조(P<0.05)。결론구역조체마취채용염산우미탁미정연합서분태니비사용사병박분연합서분태니구유교호적보조진정작용,안전성고,호흡억제정도교경。
Objective To observe the effects of regional anesthesia with dexmedetomidine hydrochloride combined with remifentanil in orthopedic surgery. Methods Three hundred and twenty patients of ASA gradeⅠorⅡscheduled for orthopedic surgery under regional block anesthesia were randomly divided into experimental group and control group, with 160 cases in each group. The experimental group applied intravenously dexmedetomidine hy-drochloride combined with remifentanil for sedation, while the control group used intravenous injection of remifent-anil combined with propofol for sedation. The two groups were recorded before administration (T0), 10 min (T1), 20 min (T2), 30 min (T3) after administration and after patients'recovery (T4) at respiratory rate (RR), mean arterial pressure (MAP), heart rate (HR), oxygen saturation (SpO2) and OAA/S score. Results At T0, T4, RR, MAP, HR, SpO2, OAA/S score showed no statistically significant difference (P>0.05). At T1, T2 and T3, RR and SPO2 in control group were significantly lower than those in experimental group (P<0.05). In the process of operation, the incidences of adverse reactions (upper airway obstruction, respiratory depression, nausea and vomiting) in control group were sig-nificantly higher than those in experiment group (P<0.05). Conclusion Regional anesthesia using dexmedetomidine hydrochloride combined with remifentanil has better auxiliary sedation than propofol combined with remifentanil, with higher safety and lighter degree of respiratory depression.